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Abstract: The hepatitis C virus (HCV) NS5B protein contains the RNA dependent RNA polymerase (RdRp) activity that 
catalyzes the synthesis of the viral genome with other host and viral factors. NS5A is an HCV-encoded protein previously 
shown to localize to the replisome and be necessary for viral replication. However, its role in replication has not been de-
fined. Using an in vitro biochemical assay, we detected a stimulatory effect of NS5A on the NS5B replication reaction 
with minimal natural templates. NS5A stimulates replication by NS5B on two templates derived from the 3’ end of the 
RNA genome (4 fold ± 1.3 fold). A pre-incubation step with the two proteins prior to the replication reaction and sub-
stoichiometric levels of NS5A are required for detecting stimulation. With a template derived from the 3’end complemen-
tary to the RNA genome (the negative strand) no stimulation was observed. Furthermore, with a synthetic template that al-
lows studying different phases of replication, NS5A stimulates NS5B during elongation. These findings suggest that 
NS5A stimulates NS5B during synthesis of the complementary (i.e., negative) strand of the RNA genome.  
INTRODUCTION 
  The HCV is a major human pathogen that belongs to the 
Flaviviridae family of viruses [1]. Understanding how the 
virus infects cells, replicates its genome, packages and exits 
the host is critical to developing new strategies to control 
viral infection. The HCV genome is a (+) strand RNA mole-
cule of ~9.6 kb containing an open reading frame (ORF) and 
flanking elements at the 3’ and 5’ ends of the untranslated 
regions (UTRs) [2, 3]. The ORF is translated into a single 
polypeptide chain that is cleaved by host and viral proteases 
into ten viral proteins (Structural: C, E1, E2, p7; and non 
structural: NS2, NS3, NS4A, NS4B, NS5A and NS5B) [3, 
4]. 
  NS5B is the RdRP that replicates the viral genome in 
vitro [5] and in vivo [6]. In vivo replication takes place in a 
membranous structure derived from the ER in a complex 
including NS5B, NS4A, NS4B, NS3, and NS5A [7-10] and 
host factors [7, 11-13]. The carboxy-terminal 21 amino-acid 
residues of NS5B are important for localization and are pre-
dicted to form a transmembrane -helix [14]. Detailed in 
vitro NS5B biochemical studies including the processes of 
nucleotide incorporation, initiation at the 3’ end, abortive 
and productive initiation, early elongation, stable elongation 
or termination, have been hampered by the poor ability of 
the protein to form catalytically competent complexes with 
the template and NTPs [15, 16]. Contrary to transcription of 
DNA, replication by HCV does not seem to require a pro-
moter region upstream of the initiation site [17]. With short 
natural templates from the genomic RNA, NS5B binds to the 
most terminal region of the 3’UTR [18, 19], and with such 
templates initiation appears to be the rate limiting step [20]. 
Additionally, NS5B does not discriminate in vitro between  
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natural and artificial templates, suggesting that additional 
viral or cellular factors may be required for template speci-
ficity. In support of this hypothesis, other viral RNA binding 
proteins (the helicase NS3 and NS5A) have been shown to 
be needed for in vivo replication [21].  
  NS5A is a phosphoprotein essential in the viral infection, 
including replication [22]. The protein has an N-terminal 
amphipathic -helix that serves as a membrane anchor [23] 
and 3 additional distinct domains [24]. Two isoforms have 
been detected: one basally phosphorylated and the other hy-
perphosphorylated [25]. The functional role of different 
phosphorylation states is not clear [26]; however, loss of 
hyperphosphorylation in NS5A is reported to stimulate repli-
cation [27, 28]. NS5A has RNA binding activity [29], can 
bind NS5B directly and has been shown to slightly stimulate 
NS5B catalytic activity with an poly (A) template/poly (U) 
primer [30]. However, the role of NS5A in replication is still 
unknown. 
  In this study, an in vitro replication assay was established 
to study the role of NS5A. When NS5B and NS5A are pre-
incubated, with NS5A at sub-stoichiometric levels, NS5B 
activity is stimulated up to 5 fold with templates derived 
from the 3’ end of the (+) strand of viral RNA. No stimula-
tion is detected when NS5B uses a template derived from the 
3’ end of the (-) strand of viral RNA. Furthermore, with a 
synthetic template that allows discrimination between initia-
tion and elongation, NS5A stimulated NS5B during elonga-
tion. These results suggest that NS5A acts perhaps by induc-
ing a conformational change in NS5B yielding a more active 
polymerase with templates derived from the 3’UTR at the 
elongation phase.  
MATERIALS AND METHODS 
Materials 
  Reagents of the highest molecular biology purity were 
purchased from Sigma Aldrich or Fisher Scientific. Radiola-40    The Open Biochemistry Journal, 2009, Volume 3  Quezada and Kane 
belled [
32P] nucleotides were purchased from Perkin Elmer. 
NTPs of the highest purity were from GE Healthcare.  
Methods 
Plasmids Constructs for Template Synthesis or Protein 
Purification 
  The plasmid containing the sequence of HCV-Con1 
genotype 1b (kind gift of Charles Rice, The Rockefeller 
University) was used as a PCR template to amplify the se-
quences of NS5A and all the natural templates. The sequence 
encoding the HCV full length NS5A (FL-NS5A) was cloned 
first into the expression vector pSPORT (Invitrogen) cleaved 
with PstI and XmaI to introduce a 10 histidine tag onto the 
C-terminus. The primers used to amplify the NS5A sequence 
were: 10HIS-F: 5’-AAACCTGCAGTCCGGCTCGTGGCT 
AAG-3’ and 10HIS-R: 5'-GTTGACCCGGGGGCAGCAGA 
CGACGTCC -3'. The NS5A-10HIS sequence was further 
cloned into the pRSET A plasmid (kind gift of Donald Rio, 
University of California-Berkeley) digested with AseI and 
HindIII. The primers used to amplify the DNA from the 
pSPORT vector were: NS5A-forward: 5’TAACATTCACAT 
ATGTCCGGCTCGTGGCTAAG-3’ and NS5A-reverse: 5’ 
GCGTACGTAAGCTTTTAG-3’. All constructs were se-
quenced for accuracy.  
  To generate the templates for RNA synthesis, pMV1 
(kind gift of Nam Vo, University of Pittsburgh), which con-
tains the T7 promoter sequence up and downstream of a mul-
tiple cloning site, was cleaved with HindIII and NcoI or 
KpnI. To generate the X (+) template, primers 98XF: 5’-
ATCAGCATCAAGCTTAATACAACTCACTATAGGT-
GGCTCCATCTTAGCCCTAGTCACGGC-3’ and 98XR: 
5’-
ATGCGAGTCCATGGACATGATCTGCAGAGAGGCCAG 
TATCAGCAC-3’ were used to amplify the HCV DNA that 
was then cleaved with Hind III and NcoI and ligated with 
pMV1 digested with the same enzymes. To generate the 
3’UTR SL (+) template, the forward primer was: 3’UTR-SL 
F: 5’-ATCAGCATCAAGCTTAATACAACTCACTATAG 
GGGATCCCCGGCTGCGTCCCAG-3’. The reverse primer 
was 98XR. Restriction enzyme digestions and ligation with 
pMV1 were as for the X (+) template. 
  To generate the 3’ END (-) template (first 341-nt of the 
complementary strand), the following primers were used: 5’ 
UTR F: 5’ATCAGCATCAAGCTTAATACAACTCACTAT 
AGGGGATCCGCCAGCCCCCCGATTGGGGGCG-3’ and 
5’ UTR R: 5’-CTCCAGAGCATCTGGCACGTGGATGG 
CTGAGCCATGGGG-3’. The PCR products and pMV1 
were cleaved with HindIII and KpnI, and ligated together. 
All constructs were sequenced after amplification in 
TOPO10 cells. 
  The LTMOA template was generated by PCR amplifica-
tion that combined a T7 RNA polymerase promoter, 
pBluescript-SK (+) sequence (674 – 914-nt), and a 21-nt G 
less sequence. The full length sequence of the LTMOA DNA 
is in supplemental material.  
RNA Template Synthesis by T7 RNA Polymerase 
  The DNA templates for the T7 in vitro transcription reac-
tions were generated from plasmids digested with MlyI [X(+) 
and 3’UTR SL (+)] or BamHI [3’END (-)]. After purification 
by gel electrophoresis, phenol extraction and ethanol 
precipitation, the DNA was dissolved in RNase free water. 
In vitro transcription reactions were carried out following the 
supplier directions at 37
oC for 4 hours (Epicentre 
Biotechnologies). After treatment with 0.1U/L DNaseI for 
30 min at 37
oC, the RNA was purified by acidic phenol 
extraction followed by two ethanol precipitations and 
centrifugation through a Bio-Spin 30 column (BioRad).  
NS5A Expression and Purification  
  Plasmid pRSET-HCV- NS5A-C10HIS was transformed 
into E. coli BL21(DE3) cells that were plated onto LB me-
dium supplemented with 0.1% Dextrose and 100 g/mL am-
picillin. A single colony was picked after 16-18 hours and 
inoculated into liquid media for overnight growth. Five mL 
of the overnight culture were used to inoculate 1 L media. 
Cells were grown at 37
oC with shaking; when the culture 
reached an OD595nm = 0.8, cells were induced with 0.5 mM 
isopropyl--D-1-thiogalactopyranoside (IPTG) for 4 hours at 
25
oC with vigorous shaking (250 RPM) after first allowing 
the culture to cool down for 10 min. Cells were then pelleted 
at 3000G for 10 min in a SS34 rotor, resuspended in 100 
mL ice cold distilled-deionized water and centrifuged again. 
The pellet was suspended in 25 mL lysis buffer [(Buffer A: 
100 mM Tris pH 8.0, 200 mM KCl) with complete-EDTA 
free protease inhibitors (Roche), leupeptin and pepstatin to a 
final concentration of 7-10 g/mL, 2% TritonX-100, and 100 
g/mL lysozyme]. The suspension was quick frozen and 
stored at -80
oC. The FL-NS5A purification was carried out 
following the 32-NS5A protocol [29] with minor differ-
ences, including detergent (0.5% Triton X-100) in all buff-
ers.  
  Pooled fractions containing the peak of NS5A were 
loaded onto a Superdex - 200 gel filtration column (GE 
Healthcare) equilibrated in buffer C (50 mM Hepes pH 7.3, 
5mM MgCl2, 400 mM KCl, 1mM DTT, 10% glycerol and 
0.1% Triton X 100). Two main peaks were observed. Frac-
tions from each peak were flash frozen before storage at -
80
oC after adding glycerol to 25% final concentration. Pro-
tein concentration was determined by the Bradford protein 
assay (Pierce).  
  A clone of NS5A lacking the first 32 amino acids (32-
NS5A) was obtained from Craig Cameron, University of 
Pennsylvania, and the protein was purified as described [29]. 
NS5B Purification 
  The FL-NS5B was purified as described [31] with minor 
modifications to increase solubility. Induction with 1mM 
IPTG was carried out in media containing 2% ethanol and 
with shaking at 16
oC [32] for 16-18H. After Ni-NTA purifi-
cation, the protein was diluted to 50 mM KCl final concen-
tration with buffer D (50 mM Hepes pH 7.3, 5mM MgCl2, 
1mM DTT, 10% glycerol and 0.1% Triton X 100) and affin-
ity purified by using a TSK-Heparin-5PW column (Tooso-
Hass) preequilibrated in buffer C with 50 mM KCl. Elution 
was carried out with a linear salt gradient from 50-700 mM 
KCl at 0.2-0.5 mL/min. Pooled fractions containing NS5B 
were concentrated with conical concentrators (5000 MWCO, 
Vivaspin), flash frozen and stored at -80
oC. Protein concen-
tration was determined by the Bradford protein assay 
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NS5B and NS5A-NS5B Replication Assay 
  NS5A was diluted in buffer E (50 mM Hepes pH 7.3, 50 
mM KCl, 5mM MgCl2, 10M ZnCl, 1mM DTT, 2% glyc-
erol and 0.1% triton X 100) and then pre-incubated with 
NS5B for 30 min on ice. NTPs (2mM ATP, 5mM GTP, 1M 
UTP, 10 M CTP), 0.5-1 M RNA template, 5 U of RNase 
inhibitor (Invitrogen), and tracer -
32P UTP (5-10 Ci – 
3000mCi/mmole, Perkin Elmer) were added in a 10 or 20 L 
reaction volume. The replication reaction was incubated at 
30
oC for 2 hours (unless otherwise stated). To stop the reac-
tion, EDTA (30 mM) and proteinase K (5-10U) were added, 
and the reactions were incubated at 55
oC for 30 min. Then an 
equal volume of formamide loading buffer (89 mM Tris-
borate, 0.025% xylene cyanol and bromophenol blue, 18 
mM EDTA, 95 % freshly deionized formamide, 0.025% 
SDS) was added; samples were heated at 95
oC for 3 min and 
loaded onto a 6% (38:2 acrylamide:bisacrylamide) polyacry-
lamide gel (PAG) containing 7M urea and TBE buffer 
(50mM Tris-borate at pH 8, 1 mM EDTA). Small gels (16 x 
22cm) were run at 20W and large gels (33 x 42 cm), at 80-
90W. Gels were exposed to a phosphorimager screen and 
scanned with a Typhoon 9400 (GE Healthcare). Quantifica-
tion was achieved by comparison of the product RNA signal 
to a standard of known concentration of the radiolabeled 
nucleotide. 
Pulse and Chase NS5B-NS5A Reactions 
  On the LTMOA template, a stalled complex was formed 
by incubating NS5B or the pre-incubated NS5B+NS5A with 
a subset of nucleotides (2mM ATP, 5mM GTP and 0.15 M 
-
32P UTP) for 30 min at 30
oC. Heparin (1mg/mL) was 
added, and the reactions were incubated for 5 min on ice. 
CTP and UTP were added to 1 mM, and the reactions were 
incubated for various times at 30
oC. To stop the reaction, 
EDTA and proteinase K (as above) were added and incu-
bated at 55
oC for 30 min. Glycogen (10 g), 0.3M sodium 
acetate and 0.1mM EDTA in 100 L volume were added 
followed by acidic phenol extraction and ethanol precipita-
tion. The pellet was resuspended into a freshly deionized 
glyoxal solution: 1.76 M glyoxal, 5% DMSO, in BES buffer 
(25mM BES, 10mM EDTA, 2mM sodium acetate, pH 6.7). 
The solution was incubated at 65
oC for 50-60 min. Glyoxal 
loading buffer (BES buffer, 0.025% xylene cyanol and bro-
mophenol blue, 5-7% glycerol) was added, and samples were 
loaded onto a pre-warmed 10 or 12% PAG containing 7M 
urea in BES buffer and run at 80-90 W in BES buffer. Gels 
were fixed (10% acetic acid, 20% methanol) and exposed to 
a phosphorimager screen as above. 
RESULTS 
  The NS5A protein is essential for HCV replication 
though its function in the process is unclear [10, 33, 34]. We 
were interested in testing the effect of NS5A on natural viral 
sequences. If there were an effect on NS5B, we also were 
interested in learning about the mechanism.  
  To test if NS5A had an effect on the NS5B mediated rep-
lication, the recombinant bacterially expressed FL-NS5A 
(Fig. 1A) or 32-NS5A (Fig. 1B) that lacks the membrane 
spanning domain, was used with FL-NS5B (Fig. 1C) during 
in vitro replication reactions.  
  The templates in these reactions were subgenomic viral 
RNAs (Fig. 1D) and part of the structural elements of the 
HCV genome essential for replication in vivo [35-39]. The 
3’UTR-SL (+) is a 401 nt RNA template that corresponds to 
the 3’UTR (+) and sequences in the coding region of NS5B 
extending from 9212 to 9601. This region contains a stem 
loop (5BSL3.2) that forms a kissing loop interaction with 
stem loop 2 of the X (+) element [40] within the 3’UTR. 
This interaction is essential for in vivo replication [40]. The 
3’UTR (+) contains a variable region, a poly (U/UC) tract 
and the X element [41, 42]. The X (+) template corresponds 
to the last 98 nucleotides of the 3’ UTR (+) [36], is con-
served among different HCV genotypes, is strictly required 
for viral replication, and folds into three stem loops [36]. The 
3’ END (-) template is a 341-nt RNA complementary to the 
sequence of the 5’UTR of the genomic RNA [43]. NS5B 
uses this sequence to initiate synthesis of the (+) strand ge-
nomic RNA during replication. This template is more effi-
cient in vitro with NS5B than templates derived from the 3’ 
















Fig. (1). Protein Purification and RNA template design. A. FL-
NS5A; B. 32- NS5A; C. FL-NS5B Proteins were purified as de-
scribed in Materials and Methods and resolved on a 10% SDS-
protein gel. D. The HCV genome arrangement and the regions used 
to generate the templates for in vitro reactions.  
 
  NS5B has low activity during in vitro reactions [5, 46], 
suggesting a requirement for additional factors to maximize 
replication efficiency. In initial work with NS5A and NS5B 
we observed a minor stimulation of RNA synthesis (data not 
shown) similar to what was observed by Shirota et al. [30]. 
This stimulation was too small to study. 
  Thus, we set out to optimize the stimulatory activity 
starting with the X (+) template. Two conditions proved key. 
One was pre-incubation of NS5A with NS5B (Fig. 2A, B). 
When NS5A is added to the reaction with no pre-incubation 
step, (Fig. 2B lane 2 and Fig. 2C) there is a 1.7 ± 0.4 fold 
stimulation over the reaction in the absence of NS5A (Fig. 
2B, compare lane 1-2 and Fig. 2C). Further addition of the 42    The Open Biochemistry Journal, 2009, Volume 3  Quezada and Kane 
NTP cocktail or the template to the NS5A pre-incubation 
step did not alter the yield of the reaction (Fig. 2B lanes 3-4 
and Fig. 2C). However, when NS5B is pre-incubated with 
NS5A prior to template addition, a significant stimulation is 
observed (3.5 ± 1.3 fold; Fig. 2B lane 5 and Fig. 2C). The 
addition of the template (Fig. 2B lane 6 and Fig. 2C) or the 
NTP cocktail (Fig. 2B lane 7 and Fig. 2C) to the pre-
incubation of NS5A-NS5B did not significantly alter the 
stimulation. In summary, NS5A stimulates NS5B replication 
when the two proteins are pre-incubated prior to the addition 
of either template or the NTP cocktail. 
  The second key condition for maximizing the stimulation 
of NS5B by NS5A was the use of sub-stoichiometric 
amounts of NS5A. The stimulation is observed only at very 
low NS5A concentrations relative to NS5B on this template 
(0.2 pM NS5A, 0.3 M NS5B). A reaction timecourse in the 
presence or absence of NS5A (Fig. 2D) indicated that stimu-
lation continued for at least 4 hours. In summary, when pre-
incubated with NS5B, NS5A at sub-stoichiometric concen-
trations stimulates the replication reaction for up to 4 hours.  
  Both, the FL- and 32-NS5A show similar stimulatory 































Fig. (2). NS5A activates NS5B during the replication reaction in an order of addition dependent manner. A. Scheme of the experimental set 
up. B. NS5B replication reactions showing components that were pre-incubated on ice for 30 minutes and the components that were added 
prior to the 30
oC incubation. Lane 1, the NS5B (0.3 M) reaction in the absence of NS5A. Lane 2, NS5A (1 pM) with no pre-incubation 
prior the replication reaction. Lanes 3-7, replication reactions with NS5A and various pre-incubation additions: NTPs (lane 3); the X(+) tem-
plate, 0.6 M (lane 4); NS5B (lane 5); NS5B and the X(+) template (lane 6); and NS5B with NTPs (lane 7). Arrow indicates the expected 
RNA product. C. Quantification of the effect of NS5A on the replication reaction (average of three independent experiments). D. Time 
course showing the reactions with NS5B () and NS5B+NS5A (). Each data point is the average of 5 experiments. In Vitro Studies of HCV Replication with the Viral NS5B and NS5A  The Open Biochemistry Journal, 2009, Volume 3    43 
tions used. As a result, we used the 32-NS5A throughout 
the rest of the study. Samples from an identical purification 
from bacterial extracts induced with a plasmid lacking NS5A 
had no stimulatory activity, indicating that NS5A is indeed 
responsible for the stimulation even at such low concentra-
tions. In addition, preliminary mutational analysis supports 
that the observed effect on NS5B is indeed due to NS5A. 
Furthermore, in the absence of NS5B no radiolabeled RNA 
products are detected, indicating that the stimulation is de-
pendent on the NS5A-NS5B interaction, and that NS5A does 
not have terminal transferase activity or other nucleotide 
polymerization activity (data not shown). The stimulation 
conditions were further optimized in 50 mM KCl and 10 M 
ZnCl2.  
  We next evaluated the template dependence of this 
stimulation. When the 3’UTR-SL (+) template is used (Fig. 
3A), similarly to the X (+) template, NS5A stimulates NS5B 
in a concentration dependent manner (Fig. 3B and C). When 
NS5A was titrated from 10 nM to 0.1 pM in the replication 
reaction (0.3 M NS5B), we again observed that sub-
stoichiometric levels of NS5A are optimal for the stimulation 
(Fig. 3B). The greatest stimulation with this template is ob-
served at 10 pM (4 ±0.6 fold) but 10 times less or more 
NS5A does not affect the yield greatly (3.8±0.6 or 3.7±1.0 
fold stimulation respectively) (Fig. 3B lanes 5-7). Concentra-
tions of 10 nM or higher begin to inhibit the reaction; thus as 
the amount of NS5A approaches that of NS5B, overall repli-
cation in vitro is reduced.  
  Templates derived from the 3’ end of the RNA negative 
strand function more efficiently in vitro with NS5B than 
templates derived from the 3’ UTR region [44, 45]. With the 
3’ END (-) template (Fig. 4A), we also consistently observe 
10-100 fold more product with NS5B alone than from tem-
plates derived from the 3’ end of the genomic (+) RNA (Fig. 
4B). Unlike results with the (+) strand derived templates, we 
detected no stimulation of NS5B by NS5A with this tem-
plate. To further test the effect of NS5A, we incubated NS5B 
at different concentrations with 10 pM NS5A (Fig. 4C) and 
at varied RNA concentrations (data not shown). In any of 
these experiments no significant stimulation on NS5B was 
observed. Taken together these results suggest that the 
stimulation of NS5B by NS5A is template dependent. These 
data further suggest that NS5A increases the ability of NS5B 
to synthesize the (-) strand and not the (+) strand.  
  To probe the mechanism of the effect of NS5A, we next 
tested synthetic templates used previously to study the bio-
chemical properties of NS5B. On one of these templates 
(LTMOA, kind gift of Dr Nam Vo, University of Pitts-
burgh), NS5A does stimulate NS5B by 3-5 fold (Fig. 5A, 
compare lanes 1-2 to 3-4).  
  The LTMOA template allows one to discriminate be-
tween RNA binding, initiation, stability of halted ternary 
complexes, and the elongation phase of RNA synthesis. The 
sequence of the 3’end of LTMOA does not contain any gua-
nidine nucleotides up to position 21. Thus, in the absence of 
CTP, NS5B initiates replication and synthesizes RNA up to 
position 21. Heparin, that prevents re-initiation, and CTP are 
added to allow elongation to resume. The stalled complex at 
position 21 (G21) continues synthesis and RNA products can 
be monitored under single cycle conditions.  
  To find out how NS5A stimulates NS5B, either NS5B 


















Fig. (3). NS5A activates the NS5B replication reaction with the 3’ UTR SL (+). A. Radiolabeled 3’UTR SL (+)template. B. NS5A titration 
during preincubation with NS5B (0.3 M) prior to starting the replication reaction: 10 nM NS5A, lane 2; 1 nM NS5A, lane 3; 100 pM 
NS5A, lane 4; 10 pM NS5A, lane 5; 1 pM NS5A, lane 6; 0.1 pM NS5A, lane 7. Lane 8 shows the reaction with NS5B alone. Arrow indicates 
the expected RNA product. C. Quantitation of stimulation of NS5B by varying amounts of NS5A. Results are the average of 2 independent 

























Fig. (4). NS5A does not activate the NS5B replication reaction with the 3’ END (-) template. A. Radiolabeled 3’ END (-) template. B. NS5B 
(2.5 M) replication reaction with the X(+) template (lane 1) or the 3’ END (-) template (2.5 M each) C. NS5B (0.3 M, lane 1, 2) plus or 
minus pre-incubated NS5A at 10 pM (lane 2). NS5B (0.2 M, lane 3, 4) plus or minus pre-incubated NS5A at 10 pM (lane 4). NS5B (0.1 
M, lane 5, 6) plus or minus pre-incubated NS5A at 10 pM (lane 6). The reaction proceeded for 2 hours at 30
oC after addition of the template 
(0.2-0.5 M), and NTPs. Arrow indicates the expected RNA product. 
UTP, GTP, and LTMOA to form G21 complexes (Fig. 5B 
lane 1). Heparin and CTP are added, and the stalled com-
plexes are incubated for up to 310 additional seconds (Fig. 
5B lanes 2-5). To resolve the sizes of the RNA products on 
denaturing gels, the reactions were treated with glyoxal to 
prevent secondary structures in the RNA products or tem-
plate annealing to the products. For data analysis, the RNA 
products are grouped into 7 regions based upon gel mobility 
(Fig. 5B). R1 corresponds to the G21 stalled complex, while 
R2 to R7 identify the accumulation of higher molecular 
weight RNA products prior to the formation of the full 
length RNA across a 90 second timecourse (Fig. 5C). The 
percent of the total products of the replication reaction in 
each region of the gel in the presence and absence of NS5A 
indicates that there is no stimulation of NS5B activity in the 
formation of the G21 complexes (Fig. 5C, R1 panel 1). 
Rather in the presence of NS5A, the G21 complex elongates 
its RNA faster into higher molecular weight RNA products 
than complexes formed only in the presence of NS5B. For 
example, after 10 seconds, 28% of the RNA molecules are 
localized at R4 when the reaction is carried out with NS5A, 
and only 15% of the RNAs are at R4 in the absence of 
NS5A. After 20 seconds the same pattern is observed (panel 
3); 31% of the RNA products are localized in R5 when 
NS5A is present, while 6% of them are in R5 in the absence 
of NS5A. No RNase has been detected in these protein frac-
tions, so degradation cannot explain these differential results. 
In summary these results suggest that NS5A stimulates 
NS5B during elongation with the LTMOA template.  
DISCUSSION 
  To study the role of NS5A in HCV replication, an in vi-
tro system was set up with recombinant NS5A and NS5B. 
We found that NS5A stimulates FL-NS5B with either the 
FL- or 32-NS5A. Additionally, detection of the stimulation 
requires a pre-incubation step and is only achieved when 
NS5A is present at sub-stoichiometric levels compared to 
NS5B, as further discussed below. 
  Co-immunoprecipitation, pull down analysis after frac-
tionation, and immunofluoresence have shown previously 
that, in vivo, a fraction of NS5A is in a complex with NS5B, 
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(a) NS5A stimulates (20%) the synthesis of a poly U mole-
cule with a 1:10 or 1:50 ratio of NS5A and NS5B, (b) binds 
directly to NS5B [30] and (c) has RNA binding properties 
[29]. Yet the specific role of NS5A in replication has re-
mained unknown.  
  Templates with natural viral sequences were tested and a 
three to five fold stimulation was observed with the tem-
plates derived from the 3’UTR (+). Interestingly, no stimula-
tion was detected with the 3’END (-) template. In addition, 
with a synthetic template that allows discrimination among 
steps in replication, we found that NS5A stimulates NS5B 
activity during elongation.  
Significance of NS5B:NS5A Preincubation 
  The requirement of a pre-incubation step argues that the 
stimulation is dependent on protein-protein interactions. The 
NS5A-NS5B protein–protein interaction would not be the 
first example of a viral RdRP regulated by another viral fac-
tor. Birnaviral RdRP (VP1) bound to a peptide fragment of 
the regulatory viral protein VP3 has been examined for 
structure and activity [51]. When the peptide fragment of 
VP3 is pre-incubated with the polymerase (VP1), 3-5 fold 
stimulation of activity is reported. Furthermore, the activa-































Fig. (5). NS5A activation of NS5B occurs during elongation on a synthetic template. A. Replication reaction with the LTMOA template (1 
M) in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of NS5A (0.2 pM) for 1 (lanes 1 and 3) and 2 hours (lanes 2 and 4) B. NS5B-
containing complexes on LTMOA can be stalled at G21 (lane 1), then released into elongation (lanes 2-5) for 20, 70, 130 and 310 seconds. 
To quantify the formation of RNA intermediates, the gel was divided into seven regions (R1-R7) for each time point. C. Quantitation of an 
experiment as in 5B with timepoints of 10 (panel 2), 20 (panel 3), 30 (panel 4), and 90 (panel 5) seconds with and without NS5A. 46    The Open Biochemistry Journal, 2009, Volume 3  Quezada and Kane 
peptide binding, that facilitates the accommodation of the 
template and incoming nucleotides for catalysis.  
  Similarly to VP1, NS5B also may require another factor 
to induce a conformational change. For HCV, the interaction 
of NS5B-NS5A could lead to the formation of a more effi-
cient NS5A-NS5B complex or alter free NS5B to a more 
efficient conformation. Perhaps NS5A changes the confor-
mation of NS5B so that the polymerase binds more selec-
tively and replicates more efficiently the 3’UTR (+) derived 
templates leading to stimulation. This hypothesis is ulti-
mately testable. Indeed, NS5B structural information sug-
gests that the purified enzyme has a “closed” form [52]. A 
unique feature of the HCV polymerase is a -hairpin in the 
thumb sub-domain, which protrudes toward the active site 
located at the base of the palm subdomain [53, 54]. This 
hairpin in the closed conformation would be predicted to 
hinder elongation during synthesis if a template contained a 
double stranded 3’ end. Indeed, this -hairpin in the closed 
conformation blocks the catalytic site when a partially dou-
ble stranded template is used [55]. When part of the -
hairpin is deleted, NS5B is able to initiate the synthesis of 
RNA on this template [55, 56]. It is possible that NS5A in-
duces movement of the NS5B -hairpin or another regula-
tory domain allowing the accommodation and elongation of 
templates. NS5B, once in its open conformation, might rec-
ognize the template without any additional aid from the fac-
tor, and this conformation may also stimulate elongation. 
Template Selective NS5A Stimulation of NS5B 
 In  vitro, purified NS5B has a very low rate of nucleotide 
incorporation (2-4 nt/sec) [46] with templates derived from 
the 3’ UTR (+) as well as with synthetic RNAs. This elonga-
tion rate contrasts with 20-200 nt/sec for a variety of other 
RNA polymerases [57], including a reported 70 nt/sec for 
poliovirus RdRP [58]. However, NS5B uses the 3’END (-) 
template very efficiently in vivo [50] and in vitro ([44, 45] 
and this work), although the mechanism of this template 
specificity is not known. NS5A stimulates replication by 
NS5B on templates derived from the 3’ UTR (+) that have a 
double stranded 3’ end and on at least one synthetic template 
with a single stranded 3’ end, yet no stimulation is detected 
on the 3’ END (-) template that also has a single stranded 3’ 
end. This result suggests that the template character of the 
replication start site is not rate limiting in the in vitro stimu-
lation by NS5A. Since NS5A has no effect on 3’ END (-) 
replication, it is possible that the 3’END (-) template itself 
enables more efficient elongation either intrinsically due to 
its sequence or because this template itself promotes a con-
formational change in NS5B that contributes to more effi-
cient replication.  
  The results with the natural templates are consistent with 
the hypothesis that NS5A enables NS5B to recognize essen-
tial elements of the RNA genome and stimulates the synthe-
sis by NS5B of the negative strand over the positive strand. 
Thus, in vivo, one role of NS5A might be the regulation of 
template utilization by NS5B. 
Replication Elongation 
  Using the LTMOA template, we found that NS5A was 
able to stimulate NS5B during elongation. NS5A does not 
decrease the number of pause sites recognized by NS5B, but 
rather changes the kinetics of RNA intermediate formation. 
The LTMOA template has a 3’ end predicted to be free of 
secondary structure so that NS5B might bind and initiate 
efficiently. Clearly NS5A does not affect the formation of 
the G21 stalled complex on this template under these condi-
tions. However, as the polymerase resumes elongation, struc-
tural or sequence elements in the template might require the 
influence of NS5A on NS5B for efficient elongation. This 
hypothesis is supported by the observation that NS5A does 
not stimulate NS5B catalytic activity on three other synthetic 
templates even though the first 21 nucleotides are identical 
to those in LTMOA. Two of these three templates have a 3’ 
end free of predicted secondary structure (data not shown). 
This result again suggests that the rate limiting step impacted 
by NS5A is not initiation. 
  Stimulation at the elongation phase is observed when 
NS5A is pre-incubated with NS5B prior to the formation of 
the G21 complex. Whether stimulation is also achieved 
when NS5A is depleted from the G21 complex before elon-
gation or when the factor is added after stalled complex for-
mation is still under investigation. These experiments will 
reveal whether NS5A forms a complex with NS5B to stimu-
late its catalytic activity or whether a conformational change 
in NS5B induced by the factor can be achieved once the po-
lymerase is in the ternary complex. The low stoichiometry 
required for detecting stimulation by NS5A suggests that it 
might act catalytically on NS5B; future experiments will 
examine this possibility. 
  With the analysis presented here, we propose that NS5A 
binds NS5B and induces a conformational change that 
“opens” NS5B. The open form might better accommodate 
elongation on defined templates. Structural studies of the 
NS5A-NS5B complex and additional biochemical analysis 
should expose the molecular details of the mechanism of 
stimulation.  
  In summary, by devising conditions to study the in vitro 
effect of factors in the HCV replication reaction, we have 
identified a role for NS5A in stimulating replication. The 
mechanism of stimulation might involve the rotation of the 
NS5B  -hairpin or other regions of NS5B that block the 
catalytic site creating a conformation that is elongation com-
petent. Further studies are needed to detail this effect of 
NS5A. Of course, in vivo replication occurs with a complex 
of host and viral factors in addition to NS5A and NS5B. The 
conditions presented in this study make it possible to explore 
the role of additional proteins in replication. These bio-
chemical studies coupled with in vivo studies will enable a 
clearer understanding of HCV replication and its regulation.  
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